Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17500
Corporate User License Price USD 750
Corporate User License Price INR 52500
Site License Price USD 500
Site License Price INR 35000
Request a Quote

Report Title

The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

The Scripps Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institute offers technology and scientific services such as antibody development and production, cell based screening, high performance computing, normal blood donor service and murine behavioral assessment, among others. It also offers undergraduate, graduate and postdoctoral programs. TSRI also organizes academic preparation and educational outreach programs. The institute operates through its research centers and institutes including Integrative Molecular Biosciences, Center for Metabolomics, Dorris Neuroscience Center, Molecular Screening Center, and others. TSRI is headquartered in La Jolla, California, the US.

The Scripps Research Institute-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 6

List of Figures 6

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

The Scripps Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11

The Scripps Research Institute, Medical Devices Deals, 2012 to YTD 2018 12

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deal Details 16

Partnerships 16

Pfizer Enters into Licensing Agreement with Scripps Research Institute 16

Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 17

Philogen Enters into Research Agreement with Scripps Research Institute 18

Verge Genomics Enters into Agreement with National Human Genome Research Institute, Scripps Research Institute and Center for Regenerative Therapies Dresden 19

GeoVax Labs Enters into Agreement with Scripps Research Institute and Institute of Human Virology 20

HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 21

Yisheng Biopharma Enters into Research Agreement with The Scripps Research Institute 22

Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine 23

Scripps Research Institute, ZIP and IME Enter into Partnership 25

aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 26

Serina Therapeutics Enters Into Research Agreement With Scripps Research Institute 28

Scripps Research Institute Expands Research Agreement With Takeda 29

Proteostasis Therapeutics Enters Into Co-Development Agreement With Scripps Research Institute 30

Scripps Research Institute Enters Into Research Agreement With Bristol-Myers Squibb 31

ChromaDex Enters Into Co-Development Agreement With Scripps Research Institute 32

Licensing Agreements 33

ChromaDex Enters into Licensing Agreement with Scripps Research Institute 33

BlinkBio Enters into Option agreement with Scripps Research Institute 34

iGenomX Enters into Licensing Agreement with Scripps Research Institute 35

ZZ Biotech Enters into Licensing Agreement with Scripps Research Institute 36

OPKO Health Enters into Licensing Agreement with Scripps Research Institute 37

Corvus Pharma Enters into Licensing Agreement with Scripps Research Institute 38

Padlock Therapeutics Enters into Licensing Agreement with Scripps Research Institute 39

Scripps Research Institute Enters into Licensing Agreement with T23 Biopharma for CD22 40

Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718 41

Cempra Enters into License Agreement with Scripps Research Institute 43

Fabrus Enters into Licensing Agreement with Scripps Research Institute 44

Zebra Biologics Enters into Licensing Agreement with Scripps Research Institute 45

Sorrento Therapeutics Enters Into Licensing Agreement With Scripps Research Institute 46

Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 47

Janssen Pharma Enters Into Licensing Agreement With Scripps Research Institute For Infectious Diseases 48

Serina Therapeutics Enters Into License Agreement With Scripps Research Institute For Click Chemistry 49

Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 50

OPKO Health Enters Into Licensing Agreement With Scripps Research Institute For SR 3306 51

Equity Offering 52

Blackthorn Therapeutics Spin Off from Scripps Research Institute 52

The Scripps Research Institute-Key Competitors 53

The Scripps Research Institute-Key Employees 54

The Scripps Research Institute-Locations And Subsidiaries 55

Head Office 55

Other Locations & Subsidiaries 55

Joint Venture 56

Recent Developments 57

Government and Public Interest 57

Sep 18, 2018: Potential drugs for ALS, Alzheimer's and Parkinson's garner USD 3 million grant 57

Sep 06, 2018: Scientists test new cancer vaccine against melanoma 58

Aug 15, 2018: Scripps Research team awarded USD 2 million to study brain circuitry driving alcohol dependence 59

Aug 14, 2018: Doctors may be able to enlist a mysterious enzyme to stop internal bleeding 60

Aug 07, 2018: New antibody analysis accelerates rational vaccine design 61

Jul 25, 2018: New strategy for cancer therapy spells double trouble for tumors 62

Jun 28, 2018: Some existing anti-cancer drugs may act in part by targeting RNA, study shows 63

Jun 26, 2018: Scripps Research scientists find new way to block alcohol addiction and ease withdrawal 65

Jun 21, 2018: Scripps Research study provides new clues to improving chemotherapies 67

Jun 19, 2018: Scientists find potential disease-fighting warheads hidden in bacteria 68

Jun 18, 2018: Scripps Research chemists design 'miniecosystems' to test drug function 69

May 30, 2018: Two-pronged antibodies draw immune killers directly to cancer cells 70

May 29, 2018: Novel RNA-modifying tool corrects genetic diseases, including driver of triple-negative breast cancer 72

May 22, 2018: Autism research to advance with USD 3.6 million NIH grant to Scripps Florida team 74

May 14, 2018: Tumor-like spheres help scientists discover smarter cancer drugs 75

May 07, 2018: New breakthrough paving the way for universal Ebola therapeutic 77

May 02, 2018: Scripps Research team receives USD 12 million grant to improve flu and malaria vaccines 78

Apr 26, 2018: Scripps Research team receives USD 7.5 million in grants for studies on cocaine, oxycodone addiction 79

Apr 19, 2018: Molecule that dilates blood vessels hints at new way to treat heart disease 80

Apr 10, 2018: Cancer researchers receive more than USD 2 million to eradicate common form of leukemia 81

Apr 03, 2018: Scripps Research discovery paves way for better flu prevention, treatment 82

Mar 05, 2018: TSRI researchers uncover culprit in Parkinson's brain cell die-off 83

Mar 01, 2018: New TSRI research points to better way to treat depression 85

Feb 28, 2018: New TSRI method accelerates studies on carbohydrate biology 86

Feb 16, 2018: The Scripps Research Institute: 'Click chemistry' reactions may boost cancer-fighting drug potency 88

Feb 16, 2018: 'Click chemistry' reactions may boost cancer-fighting drug potency 89

Feb 08, 2018: TSRI scientists take big step toward stopping cancer metastasis 90

Feb 06, 2018: TSRI receives USD 10 million grant to study effects of alcohol on the brain 91

Dec 28, 2017: New structure of key protein holds clues for better drug design 92

Dec 20, 2017: The Scripps Research Institute: Researchers get first complete look at protein behind sense of touch 94

Dec 18, 2017: The Scripps Research Institute: New study sheds light on brain changes facilitating cocaine addiction 95

Dec 11, 2017: Blueprints for anti-cancer drugs discovered in bacterial genomes 96

Dec 11, 2017: Scientists discover possible master switch for programming cancer immunotherapy 97

Dec 07, 2017: Taurine lends hand to repair cells damaged in multiple sclerosis 99

Nov 22, 2017: Scripps Research Institute: New Chemistry Method Simplifies Late-Stage Modification of Drug Compounds 101

Nov 16, 2017: Scripps Research Institute: New Painkillers Reduce Overdose Risk 102

Nov 02, 2017: Researchers Find Protein that Could Help Fight Antibiotic Resistance 103

Oct 27, 2017: Johns Hopkins Partnering with Other Institutions to Create a National Center for Health Data 104

Oct 25, 2017: New Study ‘Double Decker’ Antibody Technology Fights Cancer 105

Oct 16, 2017: Einstein Researchers Share USD 9 Million Grant to Find Anti-Aging Therapies 106

Oct 16, 2017: Scripps Florida Scientists Share USD 9 Million Grant to Develop Therapies that Target the Aging Process 107

Oct 04, 2017: HIVE Center Receives USD 27 Million in NIGMS Funding to Advance HIV Research 108

Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 109

Sep 28, 2017: Scientists Develop Broad-Spectrum Inhibitors of Influenza Viruses 110

Sep 19, 2017: Scripps Florida Scientist Awarded USD 2.5 Million Collaborative Grant to Develop New Diabetes Treatment 112

Sep 11, 2017: Outside-In Reprogramming: Antibody Study Suggests a Better Way to Make Stem Cells 113

Sep 07, 2017: Scripps Florida Scientists Confirm Quality Control Mechanism to Protect Protein Production 115

Aug 17, 2017: TSRI Awarded USD 11 Million Grant Renewal by NIAID for Long-Running Study of Immunity, Inflammation 116

Aug 07, 2017: TSRI Chemists Develop Inexpensive, Versatile Technique for Making RNA 118

Jul 31, 2017: Scripps Florida Scientists Identify Protein Deficiency Involved in Childhood Anemia and Cancers 120

Jul 31, 2017: Protein Profiling Method Reveals Many Potential New Drug Targets 121

Jun 15, 2017: Scripps Florida Scientist and Collaborators Win USD 7 Million Grant to Develop New ALS Treatments 123

Jun 14, 2017: Influenza Virus Can Overcome Potentially Crippling Mutations 124

Jun 06, 2017: TSRI Anti-Heroin Vaccine Found Effective in Non-Human Primates 126

May 31, 2017: Scripps Florida Scientist Wins USD 2 Million Grant to Study Childhood Disorder Linked to Behavioral Problems 127

May 29, 2017: New Antibiotic Packs a Punch Against Bacterial Resistance 128

May 24, 2017: TSRI Scientists Find Simple Copper Complex Shuts Down Botulinum Neurotoxin Poisoning 129

May 04, 2017: Scientists Solve Major Cancer Protein Conundrum 131

Apr 14, 2017: TSRI Chemists Devise Simple Method for Making Sought-After Boronic Acid-Based Drugs and Other Products 132

Mar 27, 2017: Scientists discover new class of anti-diabetes compounds that reduce liver glucose production 134

Feb 14, 2017: Scripps Florida Collaboration Awarded USD 3.3 Million to Develop Next-Generation Breast Cancer Therapies 135

Feb 07, 2017: Cystinosis Research Foundation Grants Support Scientific Studies on Cell Function, New Treatments and the Quest for a Cure 136

Jan 30, 2017: New TSRI Study Shows Early Brain Changes in Fragile X Syndrome 138

Jan 24, 2017: Scripps Florida team awarded USD 1.8 million grant to develop drugs for heart disease and rheumatoid arthritis 139

Product News 140

Nov 29, 2017: Scientists at TSRI and Synthorx Create the First Semi-Synthetic Organism to Encode and Translate Expanded Genetic Information into a Novel Protein with Different Non-natural Amino Acids 140

Nov 07, 2017: Researchers Discover Promising New Anticancer Strategy 141

11/07/2017: Researchers Discover Promising New Anticancer Strategy 143

Oct 26, 2017: Vanderbilt leads international effort to develop universal flu vaccine 145

Sep 04, 2017: Scripps Florida Scientists Identify Compounds That Significantly Increase Healthy Aging 146

Aug 16, 2017: TSRI Researchers Find a Way to Combat Pharmacoterrorism 147

03/16/2017: Scripps Florida scientists develop new drug delivery method for cancer therapy 149

Mar 09, 2017: Potential drug candidates halt prostate and breast cancer growth 150

Mar 08, 2018: TSRI scientists zero in on treatment for Charcot-Marie-Tooth disease 151

Other Significant Developments 153

Aug 06, 2018: Scripps Research and Bristol-Myers Squibb scientists create atomic glue gun to build better nucleic acid therapeutics 153

Oct 26, 2017: The Human Vaccines Project Launches New Initiative To Accelerate Development Of Universally Effective Influenza Vaccines 155

Appendix 156

Methodology 156

About GlobalData 156

Contact Us 156

Disclaimer 156

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 9

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11

The Scripps Research Institute, Medical Devices Deals, 2012 to YTD 2018 12

List of Tables

The Scripps Research Institute, Pharmaceuticals & Healthcare, Key Facts 2

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

The Scripps Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

The Scripps Research Institute, Deals By Therapy Area, 2012 to YTD 2018 11

The Scripps Research Institute, Medical Devices Deals, 2012 to YTD 2018 12

The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13

Pfizer Enters into Licensing Agreement with Scripps Research Institute 16

Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 17

Philogen Enters into Research Agreement with Scripps Research Institute 18

Verge Genomics Enters into Agreement with National Human Genome Research Institute, Scripps Research Institute and Center for Regenerative Therapies Dresden 19

GeoVax Labs Enters into Agreement with Scripps Research Institute and Institute of Human Virology 20

HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 21

Yisheng Biopharma Enters into Research Agreement with The Scripps Research Institute 22

Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine 23

Scripps Research Institute, ZIP and IME Enter into Partnership 25

aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 26

Serina Therapeutics Enters Into Research Agreement With Scripps Research Institute 28

Scripps Research Institute Expands Research Agreement With Takeda 29

Proteostasis Therapeutics Enters Into Co-Development Agreement With Scripps Research Institute 30

Scripps Research Institute Enters Into Research Agreement With Bristol-Myers Squibb 31

ChromaDex Enters Into Co-Development Agreement With Scripps Research Institute 32

ChromaDex Enters into Licensing Agreement with Scripps Research Institute 33

BlinkBio Enters into Option agreement with Scripps Research Institute 34

iGenomX Enters into Licensing Agreement with Scripps Research Institute 35

ZZ Biotech Enters into Licensing Agreement with Scripps Research Institute 36

OPKO Health Enters into Licensing Agreement with Scripps Research Institute 37

Corvus Pharma Enters into Licensing Agreement with Scripps Research Institute 38

Padlock Therapeutics Enters into Licensing Agreement with Scripps Research Institute 39

Scripps Research Institute Enters into Licensing Agreement with T23 Biopharma for CD22 40

Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718 41

Cempra Enters into License Agreement with Scripps Research Institute 43

Fabrus Enters into Licensing Agreement with Scripps Research Institute 44

Zebra Biologics Enters into Licensing Agreement with Scripps Research Institute 45

Sorrento Therapeutics Enters Into Licensing Agreement With Scripps Research Institute 46

Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 47

Janssen Pharma Enters Into Licensing Agreement With Scripps Research Institute For Infectious Diseases 48

Serina Therapeutics Enters Into License Agreement With Scripps Research Institute For Click Chemistry 49

Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 50

OPKO Health Enters Into Licensing Agreement With Scripps Research Institute For SR 3306 51

Blackthorn Therapeutics Spin Off from Scripps Research Institute 52

The Scripps Research Institute, Key Competitors 53

The Scripps Research Institute, Key Employees 54

The Scripps Research Institute, Other Locations 55

The Scripps Research Institute, Subsidiaries 55

The Scripps Research Institute, Joint Venture 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

The Scripps Research Institute, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person